190 related articles for article (PubMed ID: 9802922)
1. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
González-Amaro R; Portales-Pérez D; Baranda L; Abud-Mendoza C; Llorente L; Richaud-Patin Y; Alcocer-Varela J; Alarcón-Segovia D
J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
[TBL] [Abstract][Full Text] [Related]
3. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
Sierakowski S; Kucharz EJ
Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
[TBL] [Abstract][Full Text] [Related]
8. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
[TBL] [Abstract][Full Text] [Related]
9. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
Baranda L; de la Fuente H; Layseca-Espinosa E; Portales-Pérez D; Niño-Moreno P; Valencia-Pacheco G; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R
Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
[TBL] [Abstract][Full Text] [Related]
10. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
13. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
[TBL] [Abstract][Full Text] [Related]
14. Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.
Kaneoka H; Morito F; Yamaguchi M
J Clin Lab Immunol; 1989 Jan; 28(1):15-26. PubMed ID: 2470907
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
16. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.
Tanaka Y; Saito K; Suzuki H; Eto S; Yamashita U
J Immunol; 1989 Sep; 143(5):1584-90. PubMed ID: 2527267
[TBL] [Abstract][Full Text] [Related]
18. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus.
Ishida H; Kumagai S; Umehara H; Sano H; Tagaya Y; Yodoi J; Imura H
J Immunol; 1987 Aug; 139(4):1070-4. PubMed ID: 3112222
[TBL] [Abstract][Full Text] [Related]
19. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
20. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]